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he uptake and lysosomal degradation of collagen by
ﬁbroblasts constitute a major pathway in the turn-
over of connective tissue. However, the molecular
mechanisms governing this pathway are poorly understood.
Here, we show that the urokinase plasminogen activator
receptor–associated protein (uPARAP)/Endo180, a novel
mesenchymally expressed member of the macrophage
mannose receptor family of endocytic receptors, is a key
T
 
player in this process. Fibroblasts from mice with a targeted
deletion in the uPARAP/Endo180 gene displayed a near to
complete abrogation of collagen endocytosis. Furthermore,
these cells had diminished initial adhesion to a range of
different collagens, as well as impaired migration on ﬁbrillar
collagen. These studies identify a central function of uPARAP/
Endo180 in cellular collagen interactions.
 
Introduction
 
The capacity of multicellular organisms to remodel the ECM
is essential for development, homeostasis, and postnatal tissue
remodeling, but also for the progression of many degenerative
and proliferative diseases, including cancer. Both physiological
and pathological matrix remodeling depend on an intricate
interplay between cell motility factors, cell matrix adhesion
receptors, and cell surface–associated proteases (Murphy and
Gavrilovic, 1999). The interstitial collagens are the most
abundant protein constituents of connective tissues and they,
like other matrix components, are undergoing continuous
synthesis and degradation. The pathway proposed to be the
major clearance mechanism for collagen under steady-state
conditions involves the specific binding of collagen fibrils to
the cell surface, followed by the cellular uptake and degradation
of the internalized collagen in the lysosomal compartment
(Everts et al., 1996). However, unlike the alternative turnover
mechanisms that are dominated by extracellular collagen
degradation, this pathway is still poorly understood. It is
believed to be primarily operative in fibroblasts, and results
in the degradation of denatured collagen by proteases within
the acidified lysosomal environment (Kielty et al., 1993; Lee
et al., 1996; Segal et al., 2001). However, the molecular
mechanisms behind the cellular internalization of the collagen
substrate are largely unknown.
The urokinase plasminogen activator receptor–associated
protein (uPARAP)*/Endo180 is a novel multi-domain trans-
membrane glycoprotein that was identified through its specific
interaction with receptor-bound pro-urokinase plasminogen
activator on the surface of certain cultured cells (Behrendt et
al., 2000) and, independently, as a constitutive endocytic
recycling glycoprotein (Endo180) that is capable of internal-
izing mAbs directed against it (Howard and Isacke, 2002;
Sheikh et al., 2000). uPARAP/Endo180 is a member of the
macrophage mannose receptor family of type I transmembrane
glycoproteins (Engelholm et al., 2001a). The distinct and
highly conserved domain structure that characterizes this
protein family includes an NH
 
2
 
-terminal, cysteine-rich ricin
B lectin-like domain, a fibronectin type II (FN-II) domain, a
series of 8–10 domains related to C-type carbohydrate rec-
 
The online version of this article includes supplemental material.
Address correspondence to Thomas H. Bugge, Proteases and Tissue Re-
modeling Unit, Oral and Pharyngeal Cancer Branch, National Institute
of Dental and Craniofacial Research, National Institutes of Health, 30
Convent Drive, Room 211, Bethesda, MD 20892. Tel.: (301) 435-1840.
Fax: (301) 402-0823. E-mail: thomas.bugge@nih.gov
Key words: cell adhesion; integrin; matrix internalization; matrix metallo-
proteinase; uPAR
 
*Abbreviations used in this paper: FN-II, fibronectin type II; MMP, matrix
metalloproteinase; uPARAP, urokinase plasminogen activator receptor–
associated protein.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
1010 The Journal of Cell Biology 
 
|
 
 
 
Volume 160, Number 7, 2003
 
ognition domains, a transmembrane domain, and a short
COOH-terminal cytoplasmic tail (Sonnhammer et al., 1998;
Bateman et al., 1999; Engelholm et al., 2001a). uPARAP/
Endo180 is highly expressed on osteoblasts and osteocytes at
sites of endochondral and intramembranous ossification during
development (Engelholm et al., 2001b). The postnatal expres-
sion of uPARAP/Endo180 is restricted to specific subsets of fi-
broblasts, macrophages, and endothelial cells (Sheikh et al.,
2000). The biochemical functions of uPARAP/Endo180 have
yet to be elucidated. However, several conspicuous properties of
the receptor suggest that uPARAP/Endo180 may be involved
in the remodeling of the ECM and/or modulation of the local-
ization or availability of soluble ligands in the pericellular envi-
ronment (Hanasaki and Arita, 1999; Martinez-Pomares et al.,
1999; Sheikh et al., 2000; Engelholm et al., 2001a). Of particu-
lar interest, initial studies on uPARAP/Endo180 revealed that
the uPAR-dependent binding of pro-urokinase plasminogen
activator to this receptor is blocked efficiently by low concentra-
tions of collagen type V, suggesting a direct interaction with this
constituent of the ECM. This function is likely to be mediated
by the FN-II domain because this domain type is typically asso-
ciated with collagen binding (Ancian et al., 1995). In this work,
we generated a targeted deletion in the uPARAP/Endo180 gene
and show that uPARAP/Endo180 is essential for the uptake of
collagen by fibroblasts, and that it has important functions in fi-
broblast adhesion and migration on fibrillar collagen matrices.
 
Results and discussion
 
Targeted inactivation of the uPARAP/Endo180 gene 
in mice
 
We targeted the uPARAP/Endo180 gene in mice by replacing
exons 2–6 with an HPRT expression cassette (Fig. 1 A). The
correct targeting of the uPARAP/Endo180 gene was con-
Figure 1. Generation of uPARAP/Endo180-targeted mice. (A) Diagram of the targeting strategy showing the structure of the uPARAP/
Endo180-targeting vector (top), wild-type uPARAP/Endo180 allele (middle), and targeted uPARAP/Endo180 allele (bottom). Exons 2–6 of the 
uPARAP/Endo180 gene (encoding the cysteine-rich, the FN-II, and the first carbohydrate recognition domains) were replaced by the HPRT 
selection cassette. Exons are indicated with boxes and introns with a solid line. B, BamHI; E, EcoRI; H, HindIII; X, XhoI. (B) Southern blot of 
BamHI-digested mouse tail DNA from mice genotyped by PCR as uPARAP/Endo180
 /  (left lane), uPARAP/Endo180
 /  (middle lane), and 
uPARAP/Endo180
 /  (right lane). The hybridization probe (solid line below the wild-type allele in A) was located upstream of the targeted 
area. The expected DNA fragments of the wild-type (4.1 kb) and targeted (2.4 kb) alleles that hybridize to the probe are indicated with solid 
lines in A. (C) Northern blot of total RNA isolated from cultured fibroblasts. RNA from fibroblasts of mice genotyped as uPARAP/Endo180
 /  
(left lane) and uPARAP/Endo180
 /  (right lane) was hybridized with a cDNA probe complementary to the 3  end of the uPARAP/Endo180 
mRNA. (D) Western blot of lysates of cultured dermal fibroblasts from neonates genotyped as uPARAP/Endo180
 /  (left lane), uPARAP/
Endo180
 /  (middle lane), and uPARAP/Endo180
 /  (right lane). The blot was probed with a murine anti–uPARAP/Endo180 peptide antibody 
prepared as described in Materials and methods. The positions of molecular mass markers (kD) are indicated left.T
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firmed by Southern hybridization (Fig. 1 B) and by the pres-
ence of a truncated uPARAP/Endo180 transcript in mice ho-
mozygous for the insertion (uPARAP/Endo180
 
 
 
/
 
 
 
 mice), as
determined by Northern blot hybridization (Fig. 1 C). West-
ern blot analysis of extracts of cultured fibroblasts from uP-
ARAP/Endo180
 
 
 
/
 
 
 
 mice, using an antibody directed against
an epitope (residue 809–829) located outside of the intro-
duced deletion, confirmed the absence of intact uPARAP/
Endo180 (Fig. 1 D). A weak band with an apparent M
 
r
 
 of 70
kD was observed in Western blots of homozygously targeted
as well as wild-type and heterozygous mice (unpublished
data). This product was seen in all genotypes, suggesting that
it was due to a weak cross-reactivity of the antibody rather
than a putative truncated uPARAP/Endo180 gene product.
However, it should be noted that even though formation of
truncated uPARAP/Endo180 in the targeted mice could not
be formally excluded, any such product would be devoid of
the FN-II domain due to the targeting strategy (Fig. 1 A, leg-
end). uPARAP/Endo180
 
 
 
/
 
 
 
 mice were born in a Mendelian
ratio and were outwardly normal, viable, and able to repro-
duce. The observations documenting these conclusions are
summarized in Fig. S1 and legend (available at http://
www.jcb.org/cgi/content/full/jcb.200211091/DC1).
 
uPARAP/Endo180 is required for collagen internalization
 
Dermal fibroblasts abundantly express uPARAP/Endo180
(Engelholm et al., 2001b). Therefore, we generated matched
 
pairs of uPARAP/Endo180
 
 
 
/
 
 
 
 and uPARAP/Endo180
 
 
 
/
 
 
 
littermate control fibroblasts, providing an ideal tool for
studying the function of uPARAP/Endo180 in cell matrix
interactions and the association of uPARAP/Endo180 with
extracellular ligands. We investigated if uPARAP/Endo180
serves directly as an internalization receptor for collagen.
The capacity of uPARAP/Endo180
 
 
 
/
 
 
 
 fibroblasts to inter-
nalize 
 
125
 
I-labeled collagen was determined and compared
with the internalization of 
 
125
 
I-labeled holotransferrin, ma-
trix metalloproteinase (MMP)-13, and fibronectin as inde-
pendent controls.
Strikingly, the uPARAP/Endo180-deficient fibroblasts
displayed a virtually complete abrogation of the cellular up-
take of collagen types I, IV, and V (Fig. 2 A, panels 3, 4, and
1, respectively). This deficiency in collagen internalization
was observed with several independent isolates of uPARAP/
Endo180
 
 
 
/
 
 
 
 fibroblasts and could be alleviated by the rein-
troduction of uPARAP/Endo180 by transient transfection
of the cells with a uPARAP/Endo180 cDNA expression vec-
tor (Fig. 2 A, panel 2; unpublished data). In contrast, the
cellular uptake of holotransferrin, MMP-13, and fibronectin
was unaffected (Fig. 2 A, panels 5–7). The internalization
of MMP-13 has been shown previously to be uPARAP/
Endo180-independent (Bailey et al., 2002), but depends on
the low density lipoprotein receptor–related protein (LRP;
Barmina et al., 1999). Therefore, as an additional test of our
assay system, we included samples with LRP-deficient cells
Figure 2. uPARAP/Endo180 is required for collagen internalization. 
(A) Representative examples of the ability of dermal fibroblasts from uPARAP/
Endo180
 /  (black bars) or littermate uPARAP/Endo180
 /  (gray bars) 
neonates to internalize the 
125I-labeled ligands indicated above each panel. 
Col I, IV, and V designate collagen subtypes. In panel 2, uPARAP/Endo180
 /  
fibroblasts were transiently transfected with a uPARAP/Endo180 expression 
plasmid, or with a neomycin resistance gene control expression plasmid, as 
indicated. The transfection efficiency was  10%. The data are expressed as 
the total amount of 
125I-labeled ligand internalized per cell within a 3-h 
period at 37 C. Error bars indicate SDs. Asterisk in Col V, P   0.000001; 
Col V in transfected cells, P   0.000003; Col I, P   0.00000001; and Col 
IV, P   0.00005. (B) Cells with the genotype indicated were preincubated 
in the presence (hatched columns) or absence (unhatched columns) of a 
blocking antibody against  1 integrins, and the internalization of collagen V 
and I was measured as above.T
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(LRP
 
 
 
/
 
 
 
 and matched controls) in the same manner to
study the internalization of 
 
125
 
I-labeled MMP-13. This ex-
periment confirmed the essential role of LRP in this process
(P 
 
  
 
0.0007), whereas LRP deficiency had no effect on the
cellular uptake of 
 
125
 
I-labeled collagen, examined as de-
scribed for uPARAP/Endo180
 
 
 
/
 
 
 
 cells (unpublished data).
These data show that uPARAP/Endo180 has a critical and
specific role in the uptake of collagen by fibroblasts.
Fibroblasts are a dominant cell type in collagen degrada-
tion (Everts et al., 1996), but the underlying molecular
pathway is still poorly understood and only a few molecules
critical to the process have been identified. Integrin 
 
 
 
2
 
 
 
1
 
 is
known to be involved in cellular collagen interactions and
has been proposed to play a role in the initial phase of the
internalization process (Kielty et al., 1993; Lee et al., 1996;
Segal et al., 2001). Therefore, we studied the effect of anti-
body-mediated blocking of 
 
 
 
1
 
 integrins on collagen inter-
nalization by wild-type and uPARAP/Endo180
 
 
 
/
 
 
 
cells (Fig.
2 B). Strikingly, anti-
 
 
 
1 antibody had little or no effect on
internalization (hatched bars), even though the same mAb
was indeed capable of efficiently blocking 
 
 
 
1
 
 integrin func-
tion as shown in cell adhesion studies (see next section).
Thus, uPARAP/Endo180-dependent internalization of col-
lagen can occur in the absence, or at least with only very low
levels, of accessible 
 
 
 
1
 
 integrin on the cell surface.
The cellular uptake of collagen has been reported to be
insensitive to inhibitors of MMPs, serine proteases, and
cysteine proteases, and extensive degradation of collagen
before the internalization step does not seem to be needed
(Everts et al., 1988, 1989). The major degradation pro-
cesses in this pathway occur after the cellular uptake event,
by the fusion of collagen-containing intracellular vesicles
with lysosomes and the degradation of acid-denatured col-
lagen by lysosomal proteases (Everts et al., 1988, 1996;
Everts and Beertsen, 1992). Our current demonstration of
a crucial function of uPARAP/Endo180 in the actual cellu-
lar internalization of collagen thus addresses a central step
in this series of events.
 
uPARAP/Endo180-deficient cells display delayed 
adhesion to collagen matrices
 
We used a standard cell adhesion assay, in which cells are al-
lowed to attach briefly to immobilized collagens, to investi-
 
gate if the lack of uPARAP/Endo180 could directly influ-
ence cell adhesion. Loss of uPARAP/Endo180 resulted in a
50% reduction in the adhesion of fibroblasts to type V col-
lagen-coated surfaces (Fig. 3 D). This impairment was ob-
served in comparisons of several independent isolates of
uPARAP/Endo180
 
 
 
/
 
 
 
 fibroblasts with littermate control
uPARAP/Endo180
 
 
 
/
 
 
 
 fibroblasts (unpublished data). Inter-
estingly, uPARAP/Endo180
 
 
 
/
 
 
 
 cells also demonstrated a re-
duced ability to adhere to other immobilized collagens,
including purified types I and IV collagen and total ten-
don collagen (Fig. 3, A, C, and E), although the reduction
in these cases was less dramatic. In contrast, uPARAP/
Endo180 deficiency did not affect the adhesion of fibro-
blasts to a noncollagen substrate such as fibronectin (Fig. S2
C) or a surface coated with total serum proteins (Fig. 3 F). A
time-course study of cell adhesion to collagen V and col-
lagen I showed that the effect of uPARAP/Endo180 defi-
ciency was limited to the initial phase (15–30 min after plat-
ing), and wild-type and targeted cells reached the same level
of adhesion after 1–2 h (unpublished data).
Because 
 
 
 
2
 
 
 
1
 
 integrin is considered important in various
cellular interactions with collagen as stated in the previous
section, it was important to determine if the role of uPA-
RAP/Endo180 in these adhesion processes was depen-
dent on additional integrin-mediated interactions. There-
fore, we performed a new series of adhesion experiments in
the presence of the same blocking antibody against 
 
 
 
1
 
 as
used above in the internalization studies, or an irrelevant
control antibody (anti-TNP). This experiment (Fig. S2)
confirmed the central function of 
 
 
 
1
 
 in fibroblast adhesion
to collagen, as well as to fibronectin used as a positive con-
trol. Adhesion to collagen I, collagen V, and fibronectin-
coated surfaces was reduced to levels close to baseline by
the anti-
 
 
 
1
 
 antibody, irrespective of whether uPARAP/
Endo180
 
 
 
/
 
 
 
 or uPARAP/Endo180
 
 
 
/
 
  
 
fibroblasts were
used. The effect of uPARAP/Endo180 deficiency on col-
lagen adhesion observed in the absence of anti-
 
 
 
1
 
 anti-
body, however, was not due to a down-regulation of this
integrin on the targeted cells. Thus, flow cytometry analy-
sis (Fig. S3) showed that 
 
 
 
1
 
 expression levels on wild-type
and uPARAP
 
 
 
/
 
 
 
 cells were identical or closely similar. The
two cell types also had indistinguishable morphologies af-
ter plating on various matrices (Fig. S4).
Figure 3. uPARAP/Endo180 promotes cell 
adhesion to collagen. Dermal fibroblasts from 
uPARAP/Endo180
 /  (black bars) or littermate 
uPARAP/Endo180
 /  neonates (gray bars) were 
allowed to attach for 30 min at 37 C to tissue culture 
wells coated with collagens type I (A), type II (B), 
type IV (C), type V (D), total tendon collagen (E), 
or serum proteins from 10% FCS (F). The number 
of cells adhering to the different matrices was 
determined by an MTT assay and expressed as 
the percentage of adherent uPARAP/Endo180
 /  
cells. Error bars indicate SDs of quadruplicate 
determinations. The data are representative of results 
obtained with three different sets of uPARAP/
Endo180
 /  and littermate control fibroblasts. 
Asterisk in A, P   0.03; C, P   0.002; D, P   0.0004; 
and E, P   0.002.T
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These experiments revealed that uPARAP/Endo180 has
an early modulatory function in fibroblast adhesion to col-
lagen matrices, whereas 
 
 
 
1 integrins appear to be indispens-
able for this process. Thus, our observations make it tempt-
ing to speculate that uPARAP/Endo180 is critical for fully
effective initial cellular interactions with collagen, this role
having an impact on collagen adhesion, beyond its crucial
role in collagen internalization. A simple cell binding assay
with solubilized 
 
125
 
I-labeled collagen V at 4
 
 
 
C supported
this notion, as a 
 
 
 
50% reduction in binding was observed
with uPARAP/Endo180
 /  cells (unpublished data).
uPARAP/Endo180 deficiency impairs the migration 
of fibroblasts on collagen fibrils
Cell migration is intimately linked with adhesion to the
ECM (Murphy and Gavrilovic, 1999). To directly test if
uPARAP is important for cellular migration on collagen, we
performed single-cell, parallel time-lapse video microscopy
of matched pairs of primary dermal uPARAP/Endo180
 / 
and littermate control fibroblasts on a mixed fibrillar col-
lagen matrix (Fig. 4, A and B). uPARAP/Endo180
 /  cells
demonstrated a significant and reproducible impairment in
their migration, displaying a  30% reduction in the average
migration rate. The mechanistic details of this effect await
further studies. One role of uPARAP/Endo180 in cell mi-
gration may be directly related to increasing cellular adhe-
sion. However, uPARAP/Endo180-mediated collagen inter-
nalization may also promote migration by increasing
adhesion site turnover, thereby facilitating cell spreading. Fi-
nally, the interplay between uPARAP/Endo180 and inte-
grins may influence integrin-mediated signaling.
In summary, we have shown that uPARAP/Endo180, a
mesenchymal cell surface receptor, has a pivotal function
in collagen internalization, facilitates the initial adhesion of
fibroblasts to collagen, and accelerates the migration of fi-
broblasts on a fibrillar collagen matrix. The fact that uPA-
RAP/Endo180-targeted mice do not present an obvious,
aberrant phenotype makes it clear that uPARAP/Endo180
deficiency is tolerable in the absence of external challenges.
Several pathways for collagen turnover operate in parallel
(Holmbeck et al., 1999), and apparently these mechanisms
can functionally compensate for the loss of uPARAP/
Endo180 to an extent that prevents a robust presentation
of a phenotype. The generation of mice with combined de-
ficiencies in several collagen degradation pathways may
provide valuable information as to the interplay and func-
tional overlap between the pericellular and endocytic path-
ways of collagen degradation, and may shed more light on
the specific functions of uPARAP/Endo180 in vivo.
Materials and methods
uPARAP/Endo180 gene targeting
uPARAP/Endo180 gene targeting was accomplished by replacement of ex-
ons 2–6 with an HPRT cassette in embryonic stem cells, followed by the
generation of chimeric mice and interbreeding of chimeric offspring carry-
Figure 4. uPARAP/Endo180 promotes cell migration on collagen. 
(A) The migration of dermal fibroblasts from uPARAP/Endo180
 /  
(black bar) or littermate control neonates (gray bar) on total tendon 
collagen was tracked for 6 h by time-lapse video microscopy. Data 
from individual cells of each genotype were collected in parallel 
recordings, and the rate of migration was calculated by pooling four 
independent sets of experiments, each showing similar results, that 
included cells from a total of four different uPARAP/Endo180
 /  
mice and five littermate control mice. A total of 52 uPARAP/
Endo180
 /  cells and 82 control cells were included in the 
measurements. Error bars indicate the standard error of the migration 
rates. Asterisk, P   0.0016. (B) Migration paths on tendon collagen 
from 46 individual uPARAP/Endo180
 /  and 46 individual control 
fibroblasts selected randomly. The cells were tracked for 6 h by 
time-lapse microscopy. Size bar is indicated in the lower right 
corner of the control cell panel.T
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ing the disrupted uPARAP/Endo180 allele (Fig. 1 A). uPARAP/Endo180
 / 
mice were derived from two independently targeted embryonic stem cell
clones (see supplemental materials and methods for further details).
Western blot analysis
Synthesis of peptide 809–829 of the murine uPARAP/Endo180 sequence
(GenBank/EMBL/DDBJ accession no. AAC52729), immunization of rab-
bits, affinity purification of antibodies and Western blotting of cell lysates
were performed as described previously (Schnack Nielsen et al., 2002) us-
ing the antibody at a final concentration of 2  g/ml.
Ligand internalization assay
Primary skin fibroblasts were isolated from neonates as described previ-
ously (Holmbeck et al., 1999). 20  g type I collagen, type IV collagen,
type V collagen, MMP-13, human holotransferrin (all from Calbiochem-
Novachem), and human plasma fibronectin (Sigma-Aldrich) were labeled
with 
125I as described previously (Behrendt et al., 1996). Cellular ligand in-
ternalization assays were performed as described previously (Hahn-Dan-
tona et al., 2001). In brief, samples of 10
5 cells were seeded in 24-well tis-
sue culture plates and cultured in DME, 10% FCS until near confluence.
The cells were washed gently in DME at 37 C and were then cultured for
at least 1 h in binding buffer (DME, 20 mM Hepes, pH 7.4, 15 mg/ml BSA,
and 1  Nutridoma-[SP] serum substitute; Roche). The medium was re-
moved and replaced by binding buffer with 
125I-labeled protein ranging in
concentration from 0.5 to 5 nM, followed by incubation at 37 C. In some
experiments, the cells were preincubated for 30 min at 4 C with 10  g/ml
anti- 1 antibody (HA2/5) or 10  g/ml isotype-matched control anti-TNP
antibody (G235–1; both from BD Biosciences) before the addition of la-
beled ligand. The cells were then washed twice with ice-cold PBS, and in-
cubated  2 min at 4 C with 50  g/ml trypsin, 50  g/ml proteinase K, and
0.53 mM EDTA in HBSS. The detached cells were centrifuged at 3,000
rpm for 5 min at 4 C, and the radioactivity in the pellet (internalized mate-
rial) and supernatant (surface-released material) was measured in a gamma
counter. Statistical significance was calculated by two-tailed t test.
Transient transfection of primary fibroblasts
Transfection of cultured fibroblasts was performed essentially as described
previously (Kjøller and Hall, 2001), using the vector pcDNA3-uPARAP/
Endo180 (provided by Dr. Clare Isacke, Chester Beatty Laboratories, Lon-
don, UK; Sheikh et al., 2000). The transfection efficiency, estimated by de-
termination of the percentage of GFP-expressing cells after cotransfection
with pEGF-P1 (CLONTECH Laboratories, Inc.) was  10%.
Cell adhesion assay
96-well plates were coated for 1 h at 37 C with either 10% FCS in DME, or
with rat tail tendon collagen (provided by Dr. Jack Windsor, University of
Indianapolis, Indianapolis, IN), human type I collagen, murine type II col-
lagen, human type IV collagen, or human type V collagen (all from Calbio-
chem-Novabiochem), at 20  g/ml in 10 mM acetic acid. The coated wells
were washed three times with PBS, and the residual binding sites were
blocked by incubation with 0.2% BSA in PBS for 1 h at 37 C, followed by
three additional washes with PBS at RT. Primary fibroblasts were detached
by mild trypsinization, washed, resuspended in serum-free medium with
0.2% BSA, and incubated at 37 C for 30 min with gentle rotation to re-
cover from trypsinization. Cell viability was determined by Trypan blue
exclusion. 5   10
4 cells were added to each well and were allowed to at-
tach for 30 min at 37 C. Nonadherent cells were removed by two gentle
washes with 200  l PBS, and the number of adherent cells was determined
by MTT analysis (Liu et al., 2001). In some experiments, cells were prein-
cubated with anti- 1 antibody or control antibody as specified above. Sta-
tistical significance was calculated by two-tailed t test.
Cell migration assay
Tissue culture plates with a glass coverslip bottom (MatTek Corporation)
were coated with rat tail tendon collagen as described above. The dishes
were washed twice with PBS, and incubated for 1 h at 37 C with 2% heat-
denatured BSA in PBS to block residual binding sites. The integrity of the
collagen fibrils was verified by incubation with purified trypsin and MMP-9
(Netzel-Arnett et al., 2002). uPARAP/Endo180
 /  or uPARAP/Endo180-
expressing (uPARAP/Endo180
 /  or 
 / ) littermate control fibroblasts
(1,000 cells/well) were seeded overnight on the collagen layer in DME
containing 10% FCS. FCS was included during seeding and microscopy
due to the long duration of the experiments. Cell migration was analyzed
by time-lapse video microscopy as described previously (Gu et al., 1999).
In brief, cell movements were recorded using inverted microscopes (Carl
Zeiss MicroImaging, Inc.), collecting video images with tube cameras
(Newvicon model 2400; Hamamatsu Photonics) at 10-min intervals for at
least 6 h. From the individual cell tracks, cell velocities were calculated
using MetaMorph
® 4.6 software (Universal Imaging Corporation). A one-
way ANOVA and a Bonferroni multiple comparisons post-test were per-
formed using InStat
® software (GraphPad Software, Inc.) to determine the
statistical significance between samples. The experiment was repeated
with four independently isolated pairs of uPARAP/Endo180
 /  and litter-
mate-matched uPARAP/Endo180
  fibroblasts, and included a total of 52
and 82 individual measurements, respectively.
Flow cytometry
Cells were detached in PBS with 5 mM EDTA, 5 mg/ml BSA, washed twice
in binding buffer (PBS with 0.1 mg/ml CaCl2, 0.05 mg/ml MgCl2, 1 mg/ml
NaN3, and 5 mg/ml BSA), and incubated for 30 min at 4 C with either
FITC-conjugated anti- 1 integrin antibody (HA2/5) or FITC-conjugated iso-
type-matched control anti-TNP antibody (G235–1), using 5  g of antibody
for 10
6 cells in 200  l binding buffer. After incubation, cells were washed
twice in ice-cold binding buffer and fixed in 1% PFA in binding buffer
without NaN3. Flow cytometry analysis was then performed using a FAC-
sort™ instrument (Becton Dickinson).
Online supplemental material
Supplemental materials and methods, and additional primary data are
available at (http://www.jcb.org/cgi/content/full/jcb.200211091/DC1).
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